Sumitomo Mitsui Trust Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$215M Sell
3,422,813
-34,648
-1% -$2.77M 0.14% 137
2025
Q4
$330M Sell
3,457,461
-119,283
-3% -$11.7M 0.19% 101
2025
Q3
$349M Sell
3,576,744
-2,915
-0.1% -$302K 0.2% 103
2025
Q2
$384M Buy
3,579,659
+84,529
+2% +$8.55M 0.24% 88
2025
Q1
$353M Buy
3,495,130
+28,764
+0.8% +$2.9M 0.25% 82
2024
Q4
$310M Buy
3,466,366
+9,625
+0.3% +$847K 0.21% 95
2024
Q3
$290M Buy
3,456,741
+30,636
+0.9% +$2.42M 0.2% 101
2024
Q2
$264M Sell
3,426,105
-299,420
-8% -$21.9M 0.19% 105
2024
Q1
$255M Sell
3,725,525
-9,509
-0.3% -$611K 0.18% 124
2023
Q4
$216M Buy
3,735,034
+25,146
+0.7% +$1.34M 0.16% 140
2023
Q3
$196M Buy
3,709,888
+4,323
+0.1% +$227K 0.16% 132
2023
Q2
$200M Sell
3,705,565
-824,175
-18% -$43M 0.16% 136
2023
Q1
$227M Buy
4,529,740
+298,557
+7% +$14.1M 0.17% 127
2022
Q4
$196M Sell
4,231,183
-41,600
-1% -$1.8M 0.16% 146
2022
Q3
$165M Buy
4,272,783
+213,941
+5% +$8.58M 0.14% 170
2022
Q2
$151M Buy
4,058,842
+184,199
+5% +$7.5M 0.12% 201
2022
Q1
$172M Sell
3,874,643
-27,090
-0.7% -$1.17M 0.11% 194
2021
Q4
$166M Sell
3,901,733
-166,700
-4% -$7M 0.1% 217
2021
Q3
$177M Sell
4,068,433
-235,119
-5% -$10.4M 0.11% 203
2021
Q2
$184M Sell
4,303,552
-271,292
-6% -$11.4M 0.11% 212
2021
Q1
$177M Sell
4,574,844
-156,201
-3% -$5.91M 0.11% 204
2020
Q4
$170M Sell
4,731,045
-656,438
-12% -$23.7M 0.11% 202
2020
Q3
$206M Sell
5,387,483
-279,794
-5% -$10.8M 0.14% 162
2020
Q2
$199M Sell
5,667,277
-917,995
-14% -$33.1M 0.14% 159
2020
Q1
$215M Buy
6,585,272
+1,267,811
+24% +$49.5M 0.18% 123
2019
Q4
$240M Buy
5,317,461
+47,607
+0.9% +$1.99M 0.19% 114
2019
Q3
$214M Buy
5,269,854
+8,880
+0.2% +$376K 0.19% 115
2019
Q2
$226M Sell
5,260,974
-126,416
-2% -$4.86M 0.2% 106
2019
Q1
$207M Sell
5,387,390
-54,997
-1% -$2.1M 0.19% 116
2018
Q4
$189M Buy
5,442,387
+902,289
+20% +$32.7M 0.2% 111
2018
Q3
$175M Buy
4,540,098
+77,430
+2% +$2.7M 0.19% 117
2018
Q2
$146M Buy
4,462,668
+215,111
+5% +$6.49M 0.17% 133
2018
Q1
$116M Buy
4,247,557
+169,078
+4% +$4.6M 0.15% 161
2017
Q4
$101M Buy
4,078,479
+54,799
+1% +$1.51M 0.13% 181
2017
Q3
$117M Sell
4,023,680
-84,326
-2% -$2.33M 0.17% 141
2017
Q2
$114M Buy
4,108,006
+81,531
+2% +$2.16M 0.17% 140
2017
Q1
$100M Buy
4,026,475
+12,586
+0.3% +$306K 0.15% 151
2016
Q4
$86.8M Buy
4,013,889
+7,247
+0.2% +$158K 0.14% 166
2016
Q3
$95.4M Buy
4,006,642
+33,104
+0.8% +$790K 0.16% 153
2016
Q2
$92.9M Sell
3,973,538
-9,868
-0.2% -$213K 0.16% 151
2016
Q1
$74.9M Buy
3,983,406
+98,100
+3% +$1.72M 0.13% 181
2015
Q4
$72.3M Sell
3,885,306
-126,335
-3% -$2.26M 0.13% 180
2015
Q3
$65.8M Buy
4,011,641
+482,939
+14% +$8.25M 0.13% 190
2015
Q2
$62.5M Sell
3,528,702
-333,197
-9% -$5.95M 0.11% 216
2015
Q1
$68.5M Buy
3,861,899
+231,377
+6% +$3.66M 0.12% 205
2014
Q4
$48.5M Sell
3,630,522
-158,598
-4% -$2.03M 0.09% 259
2014
Q3
$44.8M Sell
3,789,120
-39,985
-1% -$504K 0.09% 267
2014
Q2
$48.9M Buy
3,829,105
+242,077
+7% +$3.15M 0.1% 241
2014
Q1
$48.5M Sell
3,587,028
-191,502
-5% -$2.51M 0.1% 234
2013
Q4
$45.4M Sell
3,778,530
-379,021
-9% -$4.48M 0.09% 246
2013
Q3
$48.8M Sell
4,157,551
-69,415
-2% -$751K 0.11% 225
2013
Q2
$39.2M Buy
+4,226,966
New +$35.9M 0.09% 268

Other funds holding BSX

Sumitomo Mitsui Trust Group's BSX Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group reduced its Boston Scientific (BSX) stake by 1% in Q1 2026, selling an estimated $2.77M and leaving 3,422,813 shares worth $215M. The position accounts for 0.14% of the portfolio, ranked #137.

Sumitomo Mitsui Trust Group first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $384M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 3,422,813 shares of Boston Scientific worth $215M as of Q1 2026.
  • Sumitomo Mitsui Trust Group sold 34,648 Boston Scientific shares in Q1 2026, an estimated $2.77M.
  • Boston Scientific made up 0.14% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #137 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • Sumitomo Mitsui Trust Group's Boston Scientific position peaked at $384M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.